Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia

BACKGROUND: We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS: NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xue Q, Chen, Wendy H, O'Connell, Dianne L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886045/
https://www.ncbi.nlm.nih.gov/pubmed/20497580
http://dx.doi.org/10.1186/1471-2407-10-231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886045/
https://www.ncbi.nlm.nih.gov/pubmed/20497580
http://dx.doi.org/10.1186/1471-2407-10-231

Ejemplares similares